D'Haens G, Taxonera C, Lopez-Sanroman A, Nos P, et al. Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol 2024 Nov 18:S2468-1253(24)00317.
PMID: 39571587